With the business potentially at an important milestone, we thought we’d take a closer look at Aurora Cannabis Inc.’s (TSE:ACB) future prospects. Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. The CA$383m market-cap company announced a latest loss of CA$55m on 31 March 2024 for its most recent financial year result. The most pressing concern for investors is Aurora Cannabis’ path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company’s growth and when analysts expect it to become profitable.
View our latest analysis for Aurora Cannabis
Consensus from 6 of the Canadian Pharmaceuticals analysts is that Aurora Cannabis is on the verge of breakeven. They expect the company to post a final loss in 2026, before turning a profit of CA$19m in…
